CLOs on the Move

Cognito Therapeutics

www.cognitotx.com

 
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer`s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer`s disease and expects to start pivotal studies in 2022. The company`s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cognitotx.com
  • 1218 Massachusetts Avenue
    Cambridge, MA USA 02138
  • Phone: 857.201.5088

Executives

Name Title Contact Details
Jennifer Newberger
 Vice President, Head of Regulatory Affairs and Compliance Profile

Similar Companies

Colorcon

Colorcon is a West Point, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CPEX Pharmaceuticals

CPEX Pharmaceuticals is a Exeter, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DocRx

At DocRX we help doctors and hospitals become more efficient, and profitable. We also help make them compliant with regulations. Visit us today!

Rafael Holdings

Rafael Holdings is focused on the development of novel cancer therapies. The company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the company is developing a pipeline of compounds focused on the regulation of cancer metabolism.

Cadila Pharmaceuticals - CPL

Cadila Pharmaceuticals - CPL, Inc. is a Chesterfield, MO-based company in the Healthcare, Pharmaceuticals, & Biotech sector.